N-Propionyl-Cysteaminylphenol-Magnetite Conjugate (NPrCAP/M) Is a Nanoparticle for the Targeted Growth Suppression of Melanoma Cells
- 1 September 2009
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 129 (9) , 2233-2241
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- 4‐S‐Cysteaminylphenol‐loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanomaCancer Science, 2007
- Involvement of Caspases 3,8, and 9 Signaling Pathways in Hyperthermia Induced Apoptosis in HL-60 CellsThermal Medicine(Japanese Journal of Hyperthermic Oncology), 2007
- Toward the Emergence of Nanoneurosurgery: Part II—Nanomedicine: Diagnostics and Imaging at the Nanoscale LevelNeurosurgery, 2006
- Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune‐response induction in transplanted syngeneic ratsThe Prostate, 2005
- Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanomaCancer Science, 2003
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats.International Journal of Oncology, 2000
- Sulfur Containing Tyrosine Analogs Can Cause Selective Melanocytotoxicity Involving Tyrosinase-Mediated ApoptosisJournal of Investigative Dermatology Symposium Proceedings, 1999
- Regulation of Translational Initiation during Cellular Responses to Stress1997
- Exploitation of Pigment Biosynthesis Pathway as a Selective Chemotherapeutic Approach for Malignant MelanomaJournal of Investigative Dermatology, 1993